CompletedNCT05481957
What is this study about?Researchers compared Vortioxetine and valprote to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.
This study has finished and is no longer accepting participants.
In HangzhouBipolarity, DepressionMedication studyAges 14–45
- Countries
- China
- Sponsor
- First Affiliated Hospital of Zhejiang University
WithdrawnNCT00817323
Official study titleWhat is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? Evidence From Selective Neurotransmitter Depletion Studies
This study was withdrawn before enrollment.
Location not clearly listedBipolarity, DepressionInterventional studyAges 19–65
- Countries
- Sponsor
- University of British Columbia
TerminatedNCT00374543
Official study titleZiprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder
This study ended early.
In BostonBipolarity, AnxietyMedication studyAges 18–75
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01172652
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoBipolarity, AnxietyMedication studyAges 18–65
- Countries
- United States
- Sponsor
- VA Palo Alto Health Care System
Not recruitingISRCTN97160532
This study isn't currently recruiting.
In TurkeyBipolarity, SchizophreniaResearch studyAges 18+
- Countries
- United States, Türkiye
- Sponsor
- The Stanley Medical Research Institute (SMRI) (USA)
CompletedNCT00034229
Official study titleA Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression
This study has finished and is no longer accepting participants.
In BethesdaBipolarity, DepressionMedication study
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT00025792
Official study titleAn Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder
This study has finished and is no longer accepting participants.
In BethesdaBipolarity, DepressionMedication study
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT01455038
Official study titleHeart Rate Variability of Patients With Bipolar Disorder in Subsyndromal Depressive Phase
This study has finished and is no longer accepting participants.
In SeoulBipolarity, DepressionObservational study
- Countries
- South Korea
- Sponsor
- Asan Medical Center
CompletedNCT00001146
Official study titleOmega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
This study has finished and is no longer accepting participants.
In BethesdaBipolarity, DepressionMedication study
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
CompletedNCT00789113
Official study titleDetermination of Bioavailability and Clearance of Lamotrigine-XR by a Stable Isotope Technique
This study has finished and is no longer accepting participants.
In MinneapolisBipolarity, DepressionMedication studyAges 65+
- Countries
- United States
- Sponsor
- University of Minnesota
CompletedNCT00242619
Official study titleRosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study
This study has finished and is no longer accepting participants.
In StanfordBipolarity, DepressionMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT05375214
Official study titleA Pilot Study of iTBS in Bipolar I Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreBipolarity, DepressionDevice studyAges 22–65
- Countries
- United States
- Sponsor
- Johns Hopkins University